Company profile: Epocrates
1.1 - Company Overview
Company description
- Provider of mobile and online clinical information and decision support software for healthcare professionals at the point of care, offering drug and disease references and diagnostic tools. Features include prescribing and safety info, interaction checks, pill identification, geolocated Bugs + Drugs resistance data, summarized clinical guidelines, and 600+ medical calculators.
Products and services
- Interaction Check: Multi-drug tool that checks potentially harmful interactions among up to 30 drugs, herbs, or supplements, delivering detailed interaction profiles for each active ingredient at the point of care
- Drug Info: Reference-grade compendium delivering prescribing and safety information for thousands of brand, generic, and OTC drugs, including precise dosing, adverse reactions, interactions, contraindications, and core pharmacology
- Calculators: Large-scale toolkit featuring over 600 medical calculators, equations, and risk scores to improve efficiency, with favoriting for quick access to most-used tools at the point of care
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Epocrates
Clinical Computer Systems
HQ: United States
Website
- Description: Provider of obstetrics-focused perinatal data and fetal monitoring solutions, including the OBIX Perinatal Data System integrating with hospital EHRs for central, bedside, and remote monitoring that supports clinical workflow and patient record integrity; OBIX BeCA bedside fetal monitor and wireless transducer system; OBIX P·O·E·T online education; and OBIX Flex professional services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Clinical Computer Systems company profile →
Fluoptics
HQ: France
Website
- Description: Provider of fluorescence imaging solutions to aid surgery, including FLUOBEAM® LX for thyroid and parathyroid surgery enabling detection of parathyroid glands with optimized image fluidity and depth of field, compatible with ambient operating room lighting; and FLUOBEAM® LM used with indocyanine green (ICG) for real-time evaluation of tissue perfusion and lymphatic system, aiding surgical decisions and reducing postoperative complications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Fluoptics company profile →
Maps Group
HQ: Italy
Website
- Description: Provider of software solutions specialized in analysis, designing and implementing innovative solutions that support decision-making processes for public and private companies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Maps Group company profile →
Proxi
HQ: Germany
Website
- Description: Provider of behavioral health technology through Proxi (http://proxi.care), a software platform designed to provide easy access to and completion of behavioral health assessments.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Proxi company profile →
Digitize AI
HQ: United States
Website
- Description: Provider of healthcare-focused AI solutions for smarter, faster prior authorization and utilization management.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Digitize AI company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Epocrates
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Epocrates
2.2 - Growth funds investing in similar companies to Epocrates
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Epocrates
4.2 - Public trading comparable groups for Epocrates
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →